FDA Inspection 1162878 — Hackensack University Medical Center
The FDA completed an inspection of Hackensack University Medical Center on February 17, 2022 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Hackensack, NJ (United States)